中文网站正在持续更新中,请密切关注我们康肽生物的最新动态,或点击访问右上角的英文官方网站 www.phoenixpeptide.com
PHOENIX PHARMACEUTICALS, INC. TOP HOME PAGE
Top Catalog English Version | My Account | 联系我们 | China



 多肽



 标记多肽 



 多肽激素文库



 抗体 



 免疫试剂盒 



 生物标志物阵列 



 多肽样品检测



 自定义肽链合成及GMP



 产品目录索取



 样品准备



 提问和解答


Gastrin Releasing Peptide and Its C-Terminal Bioactive Peptides

Tumor Biomarker and GI Peptide

Recombinant C-terminal fragments of the gastrin-releasing peptide precursor are bioactive

C-terminal fragments from the precursor for gastrin-releasing peptide (GRP) have been detected in several human tumour types. We have previously demonstrated that recombinant human proGRP42-98 is biologically active. To investigate the regions responsible, proGRP42-98 was cleaved with thrombin, and the fragments purified by HPLC. Both proGRP42-79 and proGRP80-98 stimulated proliferation of the human colorectal carcinoma cell line DLD-1, but neither peptide bound to the GRP receptor or bombesin receptor subtype 3. We conclude that two distinct regions of the proGRP C-terminus are biologically active, via a receptor distinct from the known GRP receptors. This discovery opens the way for the development of selective antagonists that may offer new therapies for proGRP-producing tumours.

Patel et al. Cancer Lett. 2007 Aug 28;254(1):87-93.

Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours

Aims: To establish whether gastrin releasing peptide (GRP) and the GRP receptor (GRPR) are expressed together in gastrointestinal carcinoid tumours.

Methods: Twenty six carcinoid tumours from the stomach, small intestine, appendix, and colorectum were investigated by immunohistochemistry for GRP and GRPR.

Results: GRP was detected in nine of 19 tumours and GRPR in 22 of 26. Coexpression of both the ligand and receptor was seen in six of 19 cases. GRPR but not GRP was more strongly expressed in appendix and colonic tumours.

Conclusions: GRP and GRPR are produced by a large number of gastrointestinal carcinoid tumours. An autocrine/paracrine pathway may exist for GRP stimulated cell proliferation in some of these neoplasms, analogous to that seen in small cell anaplastic carcinoma of the lung.

Scott et al. J Clin Pathol. 2004 February; 57(2): 189–192.

 

Plasma gastrin response with and without BIM 26226

Plasma gastrin responses before, during, and after intragastric instillation of an acidified liquid meal with and without concomitant intravenous BIM26226 in six healthy subjects. Basal as well as meal stimulated gastrin release were not significantly changed by BIM26226.

Hildebrand et al. Gut. 2001 Jul;49(1):23-8.

Mapping in Human Colon/Stomach Tissue (H-027-07)

  

Protocol for Immunohistochemistry

Tissue Sample

Human Stomach/Stomach Cancer/Colon Tissue

Fixative

10% formalin

Embedding

Paraffin

Negative Control

No primary antibody

Pretreatment

N/A

Blocking

3% H2O2, 2% Normal Goat Serum

Primary Antibody

Rabbit Anti-Gastrin Related Peptide (Human) AntiSerum (Catalog No.: H-027-07)

Optimal Dilution

1:500

Secondary Antibody

Goat Anti-Rabbit IgG, Biotinylated (1:400), 30 min

Amplification

Streptavidin-HRP (Vector), 1:400, 30 min

Detection System

HRP

Substrate

DAB (Sigma), 3 min

Counterstained

Hematoxylin, 30 sec

Mapping in Human Colon/Stomach Tissue (H-027-13)

  

Protocol for Immunohistochemistry

Tissue Sample

Human Stomach/Colon Tissue

Fixative

10% formalin

Embedding

Paraffin

Negative Control

No primary antibody

Pretreatment

N/A

Blocking

3% H2O2, 2% Normal Goat Serum

Primary Antibody

Rabbit Anti-GRP (Porcine) AntiSerum (Catalog No.: H-027-13)

Optimal Dilution

1:500

Secondary Antibody

Goat Anti-Rabbit IgG, Biotinylated (1:400), 30 min

Amplification

Streptavidin-HRP (Vector), 1:400, 30 min

Detection System

HRP

Substrate

DAB (Sigma), 3 min

Counterstained

Hematoxylin, 30 sec

Mapping in Human Lung Cancer Tissue (H-027-36)

Protocol for Immunohistochemistry

Tissue Sample

Human Lung Cancer Tissue

Fixative

10% formalin

Embedding

Paraffin

Negative Control

No primary antibody

Pretreatment

N/A

Blocking

3% H2O2, 2% Normal Goat Serum

Primary Antibody

Rabbit Anti-GRP , Pro(80-97) (Human) (Catalog No.: H-027-36)

Optimal Dilution

1:500

Secondary Antibody

Goat Anti-Rabbit IgG, Biotinylated (1:400), 30 min

Amplification

Streptavidin-HRP (Vector), 1:400, 30 min

Detection System

HRP

Substrate

DAB (Sigma), 3 min

Counterstained

Hematoxylin, 30 sec

 

Expression of gastrin-releasing peptide (GRP) in neuroblastomas

Expression of gastrin-releasing peptide (GRP) in neuroblastomas. Representative histologic sections of immunohistochemical staining with GRP antibody in neuroblastomas compared with ganglioneuromas (×100). Large mature ganglion cells show GRP protein (brown staining) in the cytoplasm.

Kim et al. Ann Surg. 2002 May; 235(5): 621–630.

GRP (Human) - EIA kit (EK-027-07)
GRP (Human) - Fluorescent EIA kit (FEK-027-07)
Linear Range: 0.17-1.69 ng/ml
Linear Range: 14.4-452 pg/ml
11 times more sensitive than normal EIA kits

 

Tips: See More Research Abstracts, Antibody Stainings, Immunoassay Kits Curves and Sequences by clicking the tabs on the top.

%Gastrin Releasing Peptide%


分类搜索
关键字搜索
按字母搜索
A B C D E F G H I J K L M N
O P Q R S T U V W X Y Z

Copyright 2022 PHOENIX BIOTECH